Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Carbone

Showing results (51-60 of 227) with videos related to

Pageof 23
Sort By:
Inflammation|August 5, 2015
Retraction Note to: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive PatientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
European Journal of Medicinal Chemistry|October 20, 2017
1,3,5-Triazines: A promising scaffold for anticancer drugs developmentStella Cascioferro, Barbara Parrino, Virginia Spanò, et al.
Journal of the American Society of Hypertension : JASH|August 29, 2018
Retraction notice to "Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies": J Am Soc Hypertens 7 (2013) 32-39Giuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of <i>Drosophila melanogaster</i>Brandon M Baker, Mary Anna Carbone, Wen Huang, et al.
Nature Communications|October 29, 2020
Genotype by environment interaction for gene expression in Drosophila melanogasterWen Huang, Mary Anna Carbone, Richard F Lyman, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 1, 2021
Correction to: Actinic keratoses: when and how to treat a single lesionAnna Carbone, Vitaliano Silipo, Laura Eibenschutz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Frontiers in Psychiatry|July 31, 2024
Applying a clinical staging model in patients affected by schizophrenia spectrum disorderRenato de Filippis, Elvira Anna Carbone, Marianna Rania, et al.
Pageof 23

Showing results (51-60 of 227) with videos related to

Sort By:
Pageof 23
Inflammation|August 5, 2015
Retraction Note to: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive PatientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
European Journal of Medicinal Chemistry|October 20, 2017
1,3,5-Triazines: A promising scaffold for anticancer drugs developmentStella Cascioferro, Barbara Parrino, Virginia Spanò, et al.
Journal of the American Society of Hypertension : JASH|August 29, 2018
Retraction notice to "Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies": J Am Soc Hypertens 7 (2013) 32-39Giuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of <i>Drosophila melanogaster</i>Brandon M Baker, Mary Anna Carbone, Wen Huang, et al.
Nature Communications|October 29, 2020
Genotype by environment interaction for gene expression in Drosophila melanogasterWen Huang, Mary Anna Carbone, Richard F Lyman, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 1, 2021
Correction to: Actinic keratoses: when and how to treat a single lesionAnna Carbone, Vitaliano Silipo, Laura Eibenschutz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 8, 2012
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Frontiers in Psychiatry|July 31, 2024
Applying a clinical staging model in patients affected by schizophrenia spectrum disorderRenato de Filippis, Elvira Anna Carbone, Marianna Rania, et al.
Pageof 23